# Efficacy and Safety of Argon Plasma Coagulation in the Treatment of Patients With Hemoptysis Caused by Endobronchial Malignancies

> **NCT03625947** · — · TERMINATED · sponsor: **University of Milan** · enrollment: 75 (actual)

## Conditions studied

- Hemoptysis
- Cancer

## Interventions

- **OTHER:** Argon Plasma Coagulation

## Key facts

- **NCT ID:** NCT03625947
- **Lead sponsor:** University of Milan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-08
- **Primary completion:** 2023-07-15
- **Final completion:** 2023-07-15
- **Target enrollment:** 75 (ACTUAL)
- **Why stopped:** Recruitment issues during pandemic (2020-2021)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03625947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03625947, "Efficacy and Safety of Argon Plasma Coagulation in the Treatment of Patients With Hemoptysis Caused by Endobronchial Malignancies". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT03625947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*